CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

le Quintás-Cardama, Alfonso
Foilsithe in Oncotarget (2018)

Molecular biology of bcr-abl1–positive chronic myeloid leukemia

le Quintás-Cardama, Alfonso, Cortes, Jorge
Foilsithe 2009

Bullet ‘Manicure’: Does Lead Prevent Hydroxyurea-induced Cutaneous Toxicity?

le Falchi, Lorenzo, Quintás-Cardama, Alfonso
Foilsithe in Jpn J Clin Oncol (2014)

MOLECULAR PATHWAYS: JAK/STAT PATHWAY: MUTATIONS, INHIBITORS, AND RESISTANCE

le Quintás-Cardama, Alfonso, Verstovsek, Srdan
Foilsithe in Clin Cancer Res (2013)

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans

le Pant, Vinod, Quintás-Cardama, Alfonso, Lozano, Guillermina
Foilsithe 2012

ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF SYSTEMIC MASTOCYTOSIS

le Quintás-Cardama, Alfonso, Jain, Nitin, Verstovsek, Srdan
Foilsithe in Cancer (2011)

The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome

le Larsson, Connie A., Cote, Gilbert, Quintás-Cardama, Alfonso
Foilsithe 2013

Investigational Immunotherapeutics for B-Cell Malignancies

le Quintás-Cardama, Alfonso, Wierda, William, O'Brien, Susan
Foilsithe in J Clin Oncol (2010)

Monitoring Molecular Response in Chronic Myeloid Leukemia

le Cortes, Jorge, Quintás-Cardama, Alfonso, Kantarjian, Hagop M.
Foilsithe in Cancer (2010)

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

le Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
Foilsithe 2009

Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

le Quintás-Cardama, Alfonso, Cortes, Jorgé E., Kantarjian, Hagop M.
Foilsithe 2011

p53 pathway dysfunction in AML: beyond TP53 mutations

le Post, Sean M., Kornblau, Steven M., Quintás-Cardama, Alfonso
Foilsithe in Oncotarget (2017)

Prognostic Impact of the MDM2(SNP309) Allele in Leukemia and Lymphoma

le Post, Sean M., Pant, Vinod, Abbas, Hussein, Quintás-Cardama, Alfonso
Foilsithe 2010

Evolution of Therapies for Chronic Myelogenous Leukemia

le Santos, Fabio P S, Kantarjian, Hagop, Quintás-Cardama, Alfonso, Cortes, Jorge
Foilsithe 2011

THE RISE AND FALL OF GAKEKEEPER MUTATIONS? THE BCR-ABL1(T315I) PARADIGM

le Gibbons, Don L., Pricl, Sabrina, Cortes, Jorge, Quintás-Cardama, Alfonso
Foilsithe in Cancer (2011)

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

le Pant, Vinod, Xiong, Shunbin, Iwakuma, Tomoo, Quintás-Cardama, Alfonso, Lozano, Guillermina
Foilsithe 2011

Prognostic Model to Identify Patients With Myelofibrosis at the Highest Risk of Transformation to Acute Myeloid Leukemia

le Quintás-Cardama, Alfonso, Kantarjian, Hagop, Pierce, Sherry, Cortes, Jorge, Verstovsek, Srdan
Foilsithe 2013

Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis

le Quintás-Cardama, Alfonso, Sever, Matjaz, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Foilsithe in Leuk Lymphoma (2013)

SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH POLYCYTHEMIA VERA

le Sever, Matjaz, Quintás-Cardama, Alfonso, Pierce, Sherry, Zhou, Lingsha, Kantarjian, Hagop, Verstovsek, Srdan
Foilsithe 2013

PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY

le Quintás-Cardama, Alfonso, Choi, Sangbum, Kantarjian, Hagop, Jabbour, Elias, Huang, Xuelin, Cortes, Jorge
Foilsithe 2014